Study finds biomarkers for psychiatric symptoms in patients

A new UC Davis study finds biomarkers that could identify patients with 22q11.2 deletion syndrome who are more likely to develop schizophrenia.

Related Keywords

, Marwa Zafarullah , Kathleen Angkustsiri , Blythep Durbin Johnson , Austin Quach , Seungjn Yeo , Heather Bowling , Department Of Biochemistry , Stanford University , Dalton Bioanalytics Inc , Uc Davis Health , Flora Tassone , Dalton Bioanalytics , Newswise , 2q 11 2 Deletion Syndrome 22q Developmental Disabilities Biomarkers Psychosis Psychiatric Symptoms , Uc Davis Mind Institute ,